Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study

INTRODUCTION: Patients with kidney failure receiving chronic haemodialysis have elevated risk of arrhythmias potentially increasing the likelihood of sudden cardiac death, stroke and hospitalisation. The DIALIZE study (NCT03303521) demonstrated that sodium zirconium cyclosilicate (SZC) was an effica...

Descripción completa

Detalles Bibliográficos
Autores principales: Fishbane, Steven, Jadoul, Michel, Dember, Laura, Kovesdy, CP, Al-Shurbaji, Ayman, Lisovskaja, Vera, Sekar, Priya, Katona, Brian, Guzman, Nicolas, Herzog, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Renal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230973/
https://www.ncbi.nlm.nih.gov/pubmed/37230521
http://dx.doi.org/10.1136/bmjopen-2022-071309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230973/
https://www.ncbi.nlm.nih.gov/pubmed/37230521
http://dx.doi.org/10.1136/bmjopen-2022-071309

Ejemplares similares